Brain aging is usually explained by neuronal dysfunction, and most rejuvenation attempts aim squarely at neurons. But the brain contains other cells that shape how neural circuits work. Oligodendrocytes, best known as producers of the myelin sheath, long stayed in the shadows. Yet they secrete extracellular matrix proteins that surround neurons and govern their plasticity. This work stands somewhat apart from neighboring studies: those look at either the brain's electrical activity or the vascular and immune mechanisms of aging, whereas here the focus is the molecular composition of the intercellular space and its effect on memory.
To see age-related changes in oligodendrocytes, researchers compared the hippocampi of young (3 months) and old (24 months) mice. They used three approaches: single-nucleus RNA sequencing, protein mass spectrometry, and bulk RNA sequencing of oligodendrocytes isolated by the O4 marker. Then they artificially raised HAPLN2 levels in young mice using a lentivirus under the control of the oligodendrocyte promoter CNP. In old mice, by contrast, they lowered it using an adeno-associated virus delivering short hairpin RNAs. Memory was tested in a radial-arm water maze and a novel object recognition test. In addition, they recorded the electrical responses of neurons in brain slices.
Aging of oligodendrocytes comes with a broad remodeling of the extracellular matrix: expression of the genes and proteins responsible for its structure rises. Among them, HAPLN2 stands out, a protein that accumulates at the nodes of Ranvier, where the nerve impulse leaps from one stretch of axon to the next. In old mice and in humans, its level in the hippocampus is elevated, especially in the CA2 and CA3 zones. Raising HAPLN2 in young mice worsened spatial memory and object memory and also altered the activity of genes linked to synaptic transmission. Lowering HAPLN2 in old mice had the opposite effect: memory improved, hyperexcitability of CA3 neurons decreased, and the expression of many matrix genes fell in a coordinated way. Importantly, microglial activity did not change, pointing to a mechanism independent of inflammation.
The work shows for the first time that oligodendrocytes actively steer cognitive aging through the extracellular matrix, rather than simply suffering from it. This shifts the focus from neurons to the intercellular environment as a therapeutic target. Unlike neighboring studies that treat the brain as an electrical or vascular network, this one demonstrates a causal link between a single matrix protein and behavior. The approach could be extended to other matrix proteins and other brain regions.
The next step is to understand exactly how HAPLN2 affects synaptic transmission: through the mechanical stiffness of the matrix, through signaling receptors, or through both routes. It would be useful to study its role in other parts of the brain, for instance in the cortex, and in models of neurodegenerative diseases where changes in HAPLN2 have already been observed. Small molecules capable of selectively lowering its levels may eventually emerge.
The results could influence gerontology, the neuroscience of memory, the development of therapies for Alzheimer's and Parkinson's disease, and our understanding of the extracellular matrix's role in brain plasticity.
Check whether the effect holds in female mice and in other species. Investigate how HAPLN2 interacts with receptors on neurons and changes their excitability.
For the neuroscience of aging, the key question is which non-cellular factors set off the cascade of cognitive decline. The work shows that the extracellular matrix may be the primary link, not a consequence. This ties aging to the fundamental problem of regulating synaptic plasticity and opens new targets for intervention.
The nodes of Ranvier, where HAPLN2 accumulates, are gaps in the myelin sheath about 1 micrometer long. That is exactly where the nerve impulse "leaps," speeding up tens of times over. In older people, there are fewer such stretches, and the signal slows down.
In Greg Egan's novel Permutation City, characters control their own biochemistry to change their personalities. Manipulating the extracellular matrix, as in this work, is a first step toward influencing memory through the molecular environment of neurons rather than through the neurons themselves.
Not published on arXiv. Here are its page, the PDF and the formalization: you can check it yourself, not only read our account.